This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Aventis Behring Gmbh. Active years: 2001.
Location History:
- Marburg-Michelbach, DE (2001)
- Marburg, DE (2001)
Company Filing History:
Years Active: 2001
Title: Hermann Karges: Innovator in Biopharmaceuticals
Introduction
Hermann Karges is a notable inventor based in Marburg-Michelbach, Germany. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of stable protein preparations. With a total of 2 patents, Karges has focused on innovations that enhance the efficacy and stability of medical solutions.
Latest Patents
Karges' latest patents include a "Stable fibrinogen solution," which is designed for use in tissue adhesives. This solution can be stored at temperatures between +4°C and +25°C for at least four weeks without losing its functional properties, particularly in terms of consistency and coagulation. Another significant patent is for "Stable transglutaminase preparations and processes for their production." This invention relates to stable forms of transglutaminase, such as factor XIII, which are readily soluble after lyophilization. The formulations include various additives and are aimed at producing pharmaceuticals for treating diseases characterized by F XIII deficiency.
Career Highlights
Karges is associated with Aventis Behring GmbH, a company known for its advancements in biopharmaceuticals. His work has contributed to the development of innovative solutions that address critical medical needs.
Collaborations
Karges has collaborated with notable colleagues, including Johann Hock and Hubert Metzner, to further enhance the impact of his inventions in the field.
Conclusion
Hermann Karges stands out as an influential inventor in the biopharmaceutical sector, with patents that promise to improve medical treatments and patient outcomes. His work continues to inspire advancements in the industry.